গলা-বুক জ্বালাপোড়া নিয়ে সচেতনতা বাড়াতে হবে
22, Nov,2022দেশে এখন গলা-বুক জ্বালাপোড়া কমাতে আধুনিক ওষুধ ব্যবহার করা হচ্ছে জানিয়ে এসকেএফ ফার্মাসিউটিক্যালসের নির্বাহী পরিচালক (বিপণন ও বিক্রয়) মোহাম্মদ মুজাহিদুল ইসলাম বলেন, নতুন আবিষ্কৃত মাল্টি ইউনিট পেলেট সিস্টেম (মাপস) এসেছে, যা গলা .....
Eskayef becomes 1st Bangladesh pharma company to export injectable products to USA
Eskayef Pharmaceuticals Limited, one of the leading pharmaceutical companies of Bangladesh, started exporting complex injectable products to the most coveted market in the world, USA.
It is the first time an injectable product from Bangladesh is being shipped to USA, according to a press release issued by Eskayef.
Earlier in September 2022, Eskayef was accredited with the prestigious US FDA approval for its injectable manufacturing facility. It is the 1st and only injectable manufacturing site in Bangladesh to achieve such a stringent accreditation.
Prior to that, .....
Eskayef makes history with US FDA approval for injectable manufacturing facility
Eskayef Pharmaceuticals Limited, one of the leading pharmaceutical companies of Bangladesh, has been accredited with the prestigious US FDA approval for its injectable manufacturing facility.
This is the first and only injectable manufacturing site in Bangladesh to achieve such a stringent accreditation, according to a press release issued by Eskayef Pharmaceuticals Limited.
This approval will allow Eskayef to export injectable pharmaceutical products from the state-of-the-art facility to the US market.
"It is a moment of great pride for .....
যুক্তরাষ্ট্রের এফডিএর অনুমোদন পেয়ে দৃষ্টান্ত গড়ল এসকেএফের ইনজেকশন তৈরির কারখানা
বিশ্বে স্বাস্থ্য খাতের সবচেয়ে মর্যাদাপূর্ণ নিয়ন্ত্রক সংস্থাগুলোর অন্যতম যুক্তরাষ্ট্রের খাদ্য ও ওষুধ প্রশাসনের (এফডিএ) অনুমোদন পেল বাংলাদেশের ওষুধশিল্প খাতের নেতৃস্থানীয় প্রতিষ্ঠান এসকেএফ ফার্মাসিউটিক্যালস লিমিটেডের .....
Transcom - Excellence and ethics sustain Bangladesh’s leading business house -stated by Newsweek
Transcom - Excellence and ethics sustain Bangladesh's leading business house Bangladesh's economic track record is impressive, to say the least, and over the past decade it has consistently been one of the world's fastest-growing economies. Real GDP growth averaged 6.8% between 2010 and 2019, supported by favorable demographics, a powerhouse manufacturing industry, and stable macroeconomic conditions. The IMF projects GDP growth will hit 6.6% in 2022, and exceed pre-pandemic levels by 2023 to reach 7.1%. The country's economic rebound will be one of the strongest and most sustained .....
ছত্রাকজনিত রোগের চিকিৎসায় প্রয়োজন জাতীয় নির্দেশিকা
বাংলাদেশে ছত্রাকজনিত রোগ বড় সমস্যা হয়ে দাঁড়িয়েছে। এই রোগ নির্মূলে ওষুধও হাতেগোনা কয়েকটি। রোগটির চিকিৎসায় জাতীয়ভাবে কোনো নির্দেশিকা নেই। যত্রতত্র স্টেরয়েড–মিশ্রিত ওষুধ ব্যবহারের ফলে ছত্রাকজনিত রোগ ড্রাগ রেজিস্ট্যান্ট .....
দেশে ‘পেনফিল’–এর প্রথম কারখানা উদ্বোধন এসকেএফের
ডায়াবেটিস চিকিৎসায় ইনসুলিন প্রয়োজন হয়। ইনজেকশনের মাধ্যমে রোগীর শরীরে প্রয়োজন অনুযায়ী ইনসুলিন দেওয়া হয়। কিছু ক্ষেত্রে শিশিতে ইনসুলিন থাকে। অন্যান্য ওষুধের মতো শিশি থেকে সুইয়ের মাধ্যমে তা বের করে রোগীর শরীরে দেওয়া হয়। আবার .....
Eskayef first to make insulin cartridges in Bangladesh
Eskayef Pharmaceuticals, one of the country's top pharmaceutical companies, has set up Bangladesh's first manufacturing facility to produce insulin cartridges, a positive development for the millions of local diabetic patients.
The state-of-the-art production plant was inaugurated yesterday aiming to start supplying the insulin penfills by the third quarter of next year following successful trials and approval from the Directorate General of Drug Administration (DGDA). Eskayef Pharmaceuticals has set up the plant in its Tongi production site with technical cooperation from .....
রোজায় ডায়াবেটিস রোগীদের চিকিৎসায় গাইডলাইন প্রকাশ
রোজায় ডায়াবেটিস রোগীদের সঠিক চিকিৎসা ব্যবস্থাপনাবিষয়ক ‘ক্লিনিক্যাল গাইডলাইন’ প্রকাশ করা হয়েছে। সারা দেশে যেসব চিকিৎসক ডায়াবেটিস রোগীদের চিকিৎসা দেন, তাঁদের কাছে শিগগিগরই এটি পৌঁছে দেওয়া হবে।
গাইডলাইনটি প্রকাশ করেছে .....
US FDA approves Eskayef for exporting solid pharmaceutical products
Eskayef Pharmaceuticals Limited, one of the leading pharmas of Bangladesh, has received approval from the US Food and Drug Administration (FDA) for its solid manufacturing facility of Faraaz Ayaaz Hossain Building (FAHB) located in Tongi, Gazipur.
এফডিএর অনুমোদন পেল এসকেএফ
গাজীপুরের টঙ্গীতে ফারাজ আয়াজ হোসেন ভবনে (এফএএইচবি) ওষুধ প্রস্তুতের সুবিধার জন্য যুক্তরাষ্ট্রের খাদ্য ও ওষুধ প্রশাসনের (ইউএস এফডিএ) অনুমোদন পেয়েছে বাংলাদেশের অন্যতম শীর্ষ ওষুধ কোম্পানি এসকেএফ ফার্মাসিউটিক্যালস .....
Paxovir reduces the risk of death and hospitalization in Corona by 89%.
Corona oral medication reduces the risk of hospitalization and death of Paxovir patients by 89 percent, experts said. They say that if the drug is given early in corona patients with mild to moderate symptoms, the severity of the virus infection will decrease.
However, caution is needed in determining the dosage and use of Paxovir. The drug can be a ‘game changer’ in the treatment of corona patients. This was stated by eminent physicians of the country, senior officials of the government's health department and public health experts while participating in the CME .....
New Paxovir will be a game-changer
The new Paxovir will be a game changer in treating Covid-19 patients with mild to moderate symptoms as it reduces the need for hospitalisation and risk of death by almost 89 percent, said speakers at a scientific seminar yesterday.
But physicians must ensure proper use of the oral antiviral drug to get the best outcome, they added.
Renowned physicians of 42 medical institutions from Bangladesh and 30 other countries participated at the discussion titled "An Update on Antivirals for Covid-19".
They also lauded Eskayef Pharmaceuticals Ltd for the fast-pace introduction of .....
Eskayef launches first US FDA-approved oral Covid medicine in Bangladesh
Eskayef Pharmaceuticals Limited, one of the leading drug manufacturing companies of Bangladesh, has received emergency use authorisation for a novel oral antiviral medicine for the treatment of Covid-19 -- world's 1st generic version of Nirmatrelvir tablets co-packaged with Ritonavir tablets -- with the brand name "Paxovir". The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for Nirmatrelvir tablets and Ritonavir tablets, co-packaged for oral use for the treatment of mild-to-moderate Covid-19 in adults and paediatric patients over 12 years of age. .....
Molnupiravir to be a game changer: Physicians
The country’s top physicians have termed molnupiravir a 'game changer' as it will fulfill the need of the medicine that physicians were waiting for to treat of the highly contagious disease, coronavirus. Thanking pharmaceutical company Eskayef for bringing the medicine to Bangladeshi market, the physicians said it will change the situation [of Covid-19] in Bangladesh. They made these remarks at a scientific seminar at a hotel in the capital on Saturday, organised by top pharmaceutical company Eskayef, where teachers, physicians and students of different medical colleges .....
Eskayef’s Covid pill hits market
Eskayef Pharmaceuticals yesterday rolled out the world's first oral anti-Covid drug Molnupiravir after the drug administration gave emergency production and marketing authorisation of the pill that is said to halve the rate of hospitalisations and deaths in high-risk Covid-19 patients.
Called Monuvir, the tablet, which costs Tk 50, is available in all drug stores and hospitals all over the country, according to Mohammad Mujahidul Islam, executive director of Eskayef's marketing and sales.
Developed by American pharmaceuticals companies Merck and Ridgeback Biotherapeutics, the .....
Oral medicine for Covid-19 now available in Bangladesh
Molnupiravir, the first oral medicine for Covid-19, is now available in the country's domestic market. Beximco Pharmaceuticals launched their generic version of the medicine, "Emorivir – 200," on Monday night. Later on Tuesday, SKF Pharmaceuticals began to supply the medicine. Square Pharmaceuticals is scheduled to bring the medicine to market within a week, and Renata Limited plans to bring the medicine within the next two weeks. The Directorate General of Drug Administration (DGDA) has so far authorised these four companies to manufacture and market Molnupiravir. Major General Md .....
Merck’s COVID-19 pill molnupiravir hits Bangladesh markets
Bangladesh’s pharmaceutical companies have begun marketing generic versions of Merck's COVID-19 antiviral drug molnupiravir, the first of its kind, upon approval from regulators.
Beximco began the sales on Tuesday after getting the emergency production and marketing authorisation on Monday, said Maj Gen Md Mahbubur Rahman, director-general of the Directorate General of Drug Administration.
Eskayef and Square Pharmaceuticals, who received nods for the production and marketing of the drug, will begin marketing the pill within the next week, reports bdnews24.com.
চিকিৎসা অধ্যয়নবিষয়ক দুটি বইয়ের মোড়ক উন্মোচন
ফিভার অ্যান্ড পাইরেক্সিয়া অব আননোন অরিজিন ও নিউমোনিয়া শিরোনামের চিকিৎসা অধ্যয়নবিষয়ক দুটি বইয়ের মোড়ক উন্মোচন করা হয়েছে।
আজ বৃহস্পতিবার এক বৈজ্ঞানিক ওয়েবিনারে বই দুটির মোড়ক উন্মোচন করা হয়। এসকেএফ ফার্মাসিউটিক্যালস .....
করোনাকালে চিকিৎসাবিজ্ঞান আরও এগিয়েছে
মেডিকেল একাডেমিক শিক্ষার ওপর লেখা দুটি বইয়ের মোড়ক উন্মোচন অনুষ্ঠানে দেশের খ্যাতনামা কয়েকজন চিকিৎসক বলেছেন, করোনাকালে সারা পৃথিবীতে জীবন ও অর্থনীতির ওপর প্রভাব পড়েছে। কিন্তু চিকিৎসাবিজ্ঞান থেমে থাকেনি, আরও এগিয়ে গেছে। .....
Development of oncology drugs in Bangladesh: A success story
Just 12 years ago, Bangladesh was a 100 percent importer of oncology drugs. Today, it is an exporter that also meets local needs. This was possible due to the efforts of local pharmaceutical companies, their far-sighted vision and the trust patients have in local products.
In the past 10 years, pharmaceutical companies such as Beacon, Eskayef, Renata, Incepta, Healthcare, and Techno Pharma have come to manufacture more than 110 types of oncological drugs. Just six to seven years ago, around 50 percent of the lifesaving medications had to be imported, posing risks of .....
Drug-makers stay strong in a tough year
Most of the industries in Bangladesh witnessed drastic fall in profits in the outgoing year due to the protracted pandemic. The pharmaceuticals industry was an exception. Complete and credible data are yet to be released, but industry leaders say the domestic market saw a handsome growth in 2020.
The industry clocked 17.36 per cent higher export growth during the July to November, bringing home $69.82 million. "The pharmaceuticals industry achieved good growth as patients have started to visit hospitals again to receive treatment and doctors are seeing patients," said Rabbur .....
Eskayef Oncology manufacturing facility gets EU GMP approval
The oncology manufacturing facility of Eskayef Pharmaceuticals, one of the finest medicine manufacturing companies in Bangladesh, has obtained the approval of European Union Good Manufacturing Practice (EU GMP) for maintaining its standard in production of oncology drugs. As a result, the people of Bangladesh can now get world class medicines in the country to treatment cancer patients. Eskayef Pharmaceuticals is the first ever Bangladeshi company to get the approval of EU GMP, a highly prestigious standard that a medicines manufacturer must meet in their production processes. The .....
A Bangladesh pharma company causes heartburn in India's drugmakers
Eskayef Pharma had been quick to take advantage of international trade rules that allow nations defined by the United Nations as least-developed countries to ignore patents and produce affordable drugs.
The Maharashtra government's decision to import Gilead's antiviral drug Remdesivir from Bangladesh drug maker Eskayef Pharmaceuticals has taken the Indian pharmaceutical industry by surprise. But analysts and legal experts pointed out that it is perfectly legal to import the drug if .....
COVID-19: Eskayef first to produce remdesivir in the country
Source: Prothom Alo
Eskayef Pharmaceuticals, one of the leading drug manufacturing companies of the country, has successfully produced remdesivir, the drug used to treat coronavirus. All procedures for production have been completed and preparations have begun from Friday morning for distribution of the drug. Managing director and chief executive officer of Eskayef, Simeen Hossain, speaking to Prothom Alo, said at this crucial time in the country, we are happy to give the people the good news that we have .....
Bangladeshi firm makes generic remdesivir
A Bangladeshi company says it has produced the first generic version of the anti-viral drug remdesivir, which is currently being tested as a possible treatment for COVID-19. "We have successfully completed all the steps in the manufacturing of remdesivir," Simeen Hossain, head of Eskayef Pharmaceuticals Bangladesh Limited, said on Friday about the production of the drug developed and patented by Gilead Sciences in the US. The announcement comes as Gilead negotiates with pharmaceutical manufacturers in India and Pakistan over the production of remdesivir for developing .....
Eskayef first to produce Remdesivir in the country
Source: The Daily Star
Eskayef Pharmaceuticals, one of the leading drug manufacturing companies of the country, has successfully produced Remdesivir, the drug used to treat coronavirus. All procedures for production have been completed and preparations have begun from Friday (today) morning for distribution of the drug. Managing Director and Chief Executive Officer of Eskayef, Simeen Hossain, speaking to The Daily Star, said at this crucial time in the country, we are happy to give the people the good news that .....
Eskayef produces Remdesivir in Bangladesh
Eskayef Pharmaceuticals Limited has completed the production of Remdisivir, the drug which is proved to be effective in treating COVID-19 patients. After completion of all production process, the company started to distribute the drug on Friday, according to a media statement. Managing Director and Chief Executive Officer of Eskayef Simeen Hossain in a media statement said, we are glad to inform you that Remdesivir, the only effective drug against coronavirus, is now at our hands. Remdesivir, a drug developed by Gilead .....